Skip to main content
On-X Valve: The Next Generation Aortic Valve.
Cardiology in review
  • Rahul Chaudhary, MD
  • Jalaj Garg, MD, Lehigh Valley Health Network
  • Parasuram Krishnamoorthy, MD
  • Neeraj Shah, MD, Lehigh Valley Health Network
  • Bruce Feldman, DO, Lehigh Valley Health Network
  • Matthew W Martinez, MD, Lehigh Valley Health Network
  • Ronald S Freudenberger, MD, Lehigh Valley Health Network
Publication/Presentation Date

The On-X valve is a newer generation mechanical bileaflet valve. Its key features include the use of pure pyrolytic carbon (devoid of silicon), a length-to-diameter ratio similar to a native valve, an inlet flared orifice, a leaflet opening up to 90 degrees, a shorter leaflet closing angle, a 2-point leaflet contact, and an actuated pivot. These features have translated into increased strength, improved valve hemodynamics, reduced hemolysis, and thrombogenicity. The 2014 American Heart Association/American College of Cardiology guidelines for the management of patients with valvular heart disease recommend an international normalized ratio (INR) of 2.5 (range, 2-3) in patients with a mechanical valve at the aortic position. However, based on the results of the Prospective Randomized On-X Anticoagulation Clinical Trial (PROACT), the Food and Drug Administration approved this valve in April 2015 in the aortic position with a lower INR goal of 1.5-2.0. This reduction in INR goals led to a statistically significant reduction in the combined endpoint of clots, bleeding events, and stroke rates with 9/patient-years for the lower INR group compared with 12/patient-years in the standard INR group. This review compares the currently available literature on the On-X valve with that of other contemporary valves.

Document Type
Citation Information

Chaudhary, R., Garg, J., Krishnamoorthy, P., Shah, N., Feldman, B. A., Martinez, M. W., & Freudenberger, R. (2017). On-X Valve: The Next Generation Aortic Valve. Cardiology In Review, 25(2), 77-83. doi:10.1097/CRD.0000000000000105